Drug Trial Radar · NCT06745336
Clinical Study of CS-001 as a Treatment for Canities (Grey Hair)
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Jun 15, 2027
Primary completion
Dec 15, 2027
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Applied Biology, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Complex Science
- First posted
- Dec 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 30 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)
Conditions
- Canities
- Grey Hair
Interventions
CS-001Drug
CS-001 Topical Treatment
Placebo Topical SolutionDrug
Placebo Topical Solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Greying Severity ScoreTime frame: Week [0,52]
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.